Organization

Greater Houston Retina Research

2 clinical trials

Clinical trial

Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial

Status: Active (not recruiting), Estimated PCD: 2026-03-20

Clinical trial

Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Status: Active (not recruiting), Estimated PCD: 2024-09-01